Company intelligence / Profile preview

RxAnte

Portland, Maine, United States

Ownership: Private
Employees: ~85
Development stage: Commercial

Overview

RxAnte’s predictive analytics platforms have demonstrated improvements in pharmacy quality measures such as CMS Star Ratings and HEDIS scores. Their Mosaic program has shown reductions in total cost of care for high-risk populations by improving prescribing practices and medication adherence. The company manages over 30 million health plan lives with proven gains in quality metrics and cost savings.

Therapeutic areas: OtherEndocrinologyCardiovascular
Modalities: Non-pharmacological therapy
Industry: Digital Health Medical Devices

Partnerships

UPMC Enterprises (strategic investor/collaborator)Major US health plans/providers using their platforms/services

Beyond the preview

Go deeper on RxAnte.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on RxAnte.

Explore the full profile